UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan
· Delayed Price · Currency is TWD 65.50
+0.10 (0.15%)
May 9, 2025, 1:15 PM CST
UnicoCell Biomed Revenue
In the year 2024, UnicoCell Biomed had annual revenue of 31.88M TWD with 29.66% growth. UnicoCell Biomed had revenue of 10.83M in the quarter ending December 31, 2024, with 34.89% growth.
Revenue
31.88M
Revenue Growth
+29.66%
P/S Ratio
124.53
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.97B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.69B |
| Sunmax Biotechnology | 1.82B |